BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#183 of 347

Mike Matson

Needham · Equity Research Analyst
EstablishedRating since 2022No new ratings since May 2025

Analyst rating accuracy & track record

Mike Matson is an equity research analyst at Needham. Bullish Whales has scored 62 of their stock calls across 12 companies. Their picks beat their sector 31% of the time over the next 12 months, and their price targets were reached 26% of the time within a year.

Win % vs sector
31%
PT Hit % (12mo)
26%
Avg sector-excess
−7.6%
Scored calls
62
Tickers
12
Tier
Established

Track record

Bullish Whales has scored 62 of Mike Matson's stock calls across 12 companies, dating back to 2022. Their rated stocks beat their own sector 31% of the time over the next 12 months. On a typical call, a Matson pick returned −7.6% more than its sector over the following year.

Of the scored calls, 62 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
INGNInogen Inc
Buy$12.00May 2025−19.0%Miss
LUCDLucid Diagnostics Inc
Buy$3.00May 2025−30.3%Miss
ESTAEstablishment Labs Holdings Inc
Buy$48.00May 2025+77.4%Hit
LIVNLivaNova PLC
Buy$64.00May 2025+50.4%Hit
ENOVEnovis Corp
Buy$57.00May 2025−39.3%Miss
VCYTVeracyte Inc
Buy$41.00May 2025+26.0%Hit
KIDSOrthopediatrics Corp
Buy$42.00May 2025−29.3%Miss
CNMDCONMED Corporation
Buy$61.00May 2025−42.4%Hit
ATRCAtriCure Inc
Buy$44.00Apr 2025−12.8%Miss
NEONeoGenomics Inc
Buy$8.50Apr 2025+36.6%Hit
LUCDLucid Diagnostics Inc
Buy$3.00Apr 2025−1.1%Miss
PSNLPersonalis Inc
Buy$7.00Apr 2025+74.3%Hit
KIDSOrthopediatrics Corp
Buy$42.00Apr 2025−38.2%Miss
ENOVEnovis Corp
Buy$64.00Apr 2025−37.9%Miss
ENOVEnovis Corp
Buy$64.00Apr 2025−37.4%Miss
ATRCAtriCure Inc
Buy$51.00Mar 2025−10.2%Miss
LUCDLucid Diagnostics Inc
Buy$3.00Mar 2025−24.0%Miss
ATRCAtriCure Inc
Buy$51.00Mar 2025−15.3%Miss
HAEHaemonetics Corporation
Buy$104.00Mar 2025−10.7%Miss
LIVNLivaNova PLC
Buy$64.00Mar 2025+50.8%Hit
KIDSOrthopediatrics Corp
Buy$42.00Mar 2025−34.0%Miss
PSNLPersonalis Inc
Buy$7.00Feb 2025+112.6%Hit
ENOVEnovis Corp
Buy$64.00Feb 2025−43.6%Miss
LIVNLivaNova PLC
Buy$64.00Feb 2025+64.7%Hit
VCYTVeracyte Inc
Buy$51.00Feb 2025−8.1%Miss
NEONeoGenomics Inc
Buy$18.00Feb 2025−24.3%Miss
ATRCAtriCure Inc
Buy$51.00Feb 2025−31.1%Miss
CNMDCONMED Corporation
Buy$91.00Feb 2025−46.4%Miss
VCYTVeracyte Inc
Buy$51.00Jan 2025−22.3%Miss
LIVNLivaNova PLC
Buy$75.00Jan 2025+18.2%Miss
ATRCAtriCure Inc
Buy$51.00Jan 2025−12.7%Miss
NEONeoGenomics Inc
Buy$19.00Jan 2025−21.4%Miss
KIDSOrthopediatrics Corp
Buy$42.00Jan 2025−43.6%Miss
NEONeoGenomics Inc
Buy$19.00Jan 2025−14.3%Miss
PSNLPersonalis Inc
Buy$7.25Jan 2025+34.6%Hit
PSNLPersonalis Inc
Buy$7.25Dec 2024+32.7%Hit
LIVNLivaNova PLC
Buy$75.00Nov 2024+14.3%Miss
LUCDLucid Diagnostics Inc
Buy$2.50Nov 2024−0.5%Miss
LIVNLivaNova PLC
Buy$75.00Nov 2024−0.3%Miss
KIDSOrthopediatrics Corp
Buy$42.00Nov 2024−33.0%Miss
PSNLPersonalis Inc
Buy$7.25Nov 2024+53.3%Hit
ENOVEnovis Corp
Buy$65.00Nov 2024−38.6%Miss
NEONeoGenomics Inc
Buy$19.00Nov 2024−33.9%Hit
CNMDCONMED Corporation
Buy$97.00Oct 2024−36.0%Miss
LIVNLivaNova PLC
Buy$75.00Oct 2024+3.6%Miss
CNMDCONMED Corporation
Buy$97.00Oct 2024−23.6%Miss
KIDSOrthopediatrics Corp
Buy$42.00Sep 2024−25.3%Miss
LUCDLucid Diagnostics Inc
Buy$2.50Aug 2024+29.6%Miss
ENOVEnovis Corp
Buy$65.00Aug 2024−22.7%Miss
CNMDCONMED Corporation
Buy$97.00Aug 2024−11.3%Miss
Go to

Mike Matson: analyst track record FAQ

Is Mike Matson a good stock analyst?

Yes, by track record. Mike Matson ranks number 183 of 347 of the analysts Bullish Whales scores, with a BW Score of 27 out of 100. Past results do not guarantee future ones.

What is Mike Matson's win rate?

Mike Matson's win rate is 31%. Across 62 scored calls, their rated stocks beat their sector 31% of the time over the next 12 months. On a typical call they returned −7.6% more than the sector.

What stocks and sectors does Mike Matson cover?

Mike Matson covers 12 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Mike Matson's price targets accurate?

Mike Matson's price targets are reached within 12 months 26% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Mike Matson's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Mike Matson rank among Wall Street analysts?

Mike Matson ranks number 183 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30